Licorice Root Extract for Hyperpigmentation: Glabridin, B16 Melanoma Inhibition, and 2026 Formulation Science

Formulation Guide: Brightening Ampoule with Licorice Root Extract

Target Product Profile

• Type: Water-based brightening ampoule (high-active, low-viscosity)
• Target pH: 5.5-6.5
• Target markets: Southeast Asia (humid tropical climate)
• Format: 10 mL glass ampoule or 30 mL dropper bottle
• Shelf life: 18 months (preserved system required)

Ingredient Palette

Key Formulation Notes

Extract standardization: Specify your licorice extract by glabridin content, not just extract name. A 10% glabridin-standardized extract at 2% addition delivers approximately 0.2% glabridin to the final formula — clinically effective based on published studies. Some suppliers offer 20% or 40% standardized extracts for more concentrated formulations.

Solubility and formulation: Glabridin is fat-soluble (log P ~3.5). A water-based formulation must use a solubilized or dispersed form. Liposomal licorice extract or a microemulsion delivery system significantly improves bioavailability compared to simple aqueous extracts. Alternatively, use a standardized oil-soluble licorice extract (e.g., Glycyrrhiza Glabra Root Oil) at 0.1-0.5% in an oil phase for an emulsion-based product.

Synergy with Alpha Arbutin: Combining licorice root extract with alpha arbutin targets melanogenesis through three distinct pathways simultaneously: direct tyrosinase inhibition (glabridin), substrate competition (alpha arbutin), and melanosome transfer suppression (niacinamide). This multi-pathway approach is significantly more effective than single-active formulations for stubborn hyperpigmentation.

Synergy with Centella: Centella asiatica’s asiaticoside and madecassoside compounds complement licorice’s anti-inflammatory activity through the NF-κB pathway, providing enhanced protection against PIH triggers.

Stability: Glabridin is light-sensitive. Package in amber glass or opaque secondary packaging. Final formula pH should be maintained between 4.5 and 7.0 to avoid hydrolysis. Accelerated stability testing at 40°C/75% RH for 8 weeks is recommended prior to launch.

Preservation: Licorice extract contains natural saponins and sugars that can support microbial growth. Use a broad-spectrum preservative system (phenoxyethanol + EHGP at 0.8-1.0% or equivalent). Challenge test to USP 51 standard is mandatory.

Process

Regulatory Status

Licorice root extract (Glycyrrhiza Glabra Root Extract) is approved for cosmetic use across all major markets:

• EU: Listed in CosIng database. Safe for use in all cosmetic categories within standard concentrations.
• ASEAN: Listed in the ASEAN Cosmetic Ingredient (ACI) list. No special restrictions at typical use levels (1-10%).
• Japan: Listed in the Japanese Standards of Quasi-Drug Ingredients (JQJ). Commonly used in skin-brightening quasi-drug products.
• South Korea: Listed in the Korea Cosmetic Ingredient Bank (KCIA). Widely used in functional cosmetics for whitening claims.
• China: Licorice extract is permitted in cosmetics. The ingredient Glycyrrhiza Glabra (Licorice) Root Extract appears in the China NMPA approved cosmetic ingredient list.

Note: Glycyrrhizin in high concentrations may cause mineralocorticoid effects if absorbed systemically in very large quantities. This is not a concern for topical cosmetic use at specified concentrations. However, avoid use in products intended for application to large areas of broken skin.

Formulation Checklist

• [ ] Specify licorice extract by glabridin content (not generic extract name)
• [ ] pH stability confirmed at 40°C for 8 weeks
• [ ] Challenge test (USP 51) passed
• [ ] Human repeat insult patch test (HRIPT) for skin sensitization
• [ ] In-use stability study at tropical conditions (35°C/75% RH)
• [ ] Photostability testing if claiming UV protection or anti-pollution
• [ ] Claims substantiation: in vitro tyrosinase inhibition data + in vivo clinical evidence or consumer perception study

Summary

Licorice root extract is a multi-pathway skin-brightening active that differentiates from single-mechanism actives like kojic acid or arbutin through its combination of direct tyrosinase inhibition, anti-inflammatory activity, and MSH signaling modulation. Clinical evidence supports its efficacy in reducing melasma, PIH, and UV-induced hyperpigmentation in diverse skin types — including the darker Fitzpatrick types prevalent in Southeast Asian markets.

Formulation success depends on three factors: sourcing a glabridin-standardized extract, using appropriate delivery technology for the fat-soluble actives, and pairing with complementary actives that address different nodes of the melanogenesis cascade.

References

Among the botanically-derived tyrosinase inhibitors available to the modern formulation scientist, licorice root extract occupies a uniquely broad mechanism of action profile. While many brightening actives target a single step in the melanogenesis cascade, licorice-derived compounds engage multiple pathways simultaneously — from direct enzyme inhibition to oxidative stress suppression — making them unusually versatile primary or secondary actives in leave-on formulations targeting hyperpigmentation.

This article covers the key bioactive compounds in licorice root, the clinical evidence base, and the practical formulation science required to develop stable, effective brightening products for Southeast Asian markets.

Botanical Background: What Is Licorice Root?

Licorice root (Glycyrrhiza glabra, Fabaceae family) has been used in traditional medicine across Asia, the Middle East, and Southern Europe for millennia. Its skin-brightening applications have been documented in Ayurvedic and Traditional Chinese Medicine texts for over 3,000 years.

The key skin-brightening bioactives in licorice root include:

• Glabridin — The primary isoflavan responsible for licorice’s tyrosinase-inhibitory activity. Isolated from the hydrophobic fraction of licorice root extract.
• Licochalcone A / Licochalcone E — Chalcone-type polyphenols with potent antioxidant and anti-inflammatory activity.
• Glycyrrhizin / Glycyrrhizic Acid — A triterpenoid saponin with anti-inflammatory properties; often removed in high-purity licorice extracts to avoid sensitization.
• Isoliquiritigenin — A chalcone with tyrosinase-inhibitory and anti-oxidative properties.

Mechanism of Action

Direct Tyrosinase Inhibition (Glabridin)

Glabridin is a non-competitive (mixed-type) inhibitor of human tyrosinase — distinct from the competitive inhibition profile of kojic acid or arbutin. This non-competitive binding mode means glabridin can inhibit the enzyme even when substrate concentrations are high, providing a more robust and less easily overcome mechanism of action.

Published kinetic studies demonstrate that glabridin’s inhibition constant (Ki) against mushroom tyrosinase is in the low micromolar range, comparable to or exceeding that of standard reference inhibitors. Its effect on B16-F10 mouse melanoma cells — a standard model for melanin synthesis studies — shows dose-dependent suppression of melanin content at concentrations non-toxic to the host cell.

Anti-Inflammatory and Antioxidant Effects

Licochalcone A and glycyrrhizin suppress UV-induced inflammatory mediators including prostaglandin E2 (PGE2), COX-2, and various cytokines that upregulate melanogenesis through the p38 MAPK and NF-κB signaling pathways. This is clinically significant because post-inflammatory hyperpigmentation (PIH) — one of the most common pigmentation concerns in Southeast Asia — is driven as much by inflammation as by UV exposure.

MSH and cAMP Pathway Modulation

Recent research (Fu et al., 2023) has demonstrated that licorice flavonoids modulate the α-MSH (melanocyte-stimulating hormone) signaling axis, reducing cAMP accumulation in melanocytes and thereby decreasing tyrosinase gene expression through the MITF transcription factor pathway — a secondary but clinically meaningful mechanism of action that complements direct enzyme inhibition.

Clinical Evidence

Formulation Guide: Brightening Ampoule with Licorice Root Extract

Target Product Profile

• Type: Water-based brightening ampoule (high-active, low-viscosity)
• Target pH: 5.5-6.5
• Target markets: Southeast Asia (humid tropical climate)
• Format: 10 mL glass ampoule or 30 mL dropper bottle
• Shelf life: 18 months (preserved system required)

Ingredient Palette

Key Formulation Notes

Extract standardization: Specify your licorice extract by glabridin content, not just extract name. A 10% glabridin-standardized extract at 2% addition delivers approximately 0.2% glabridin to the final formula — clinically effective based on published studies. Some suppliers offer 20% or 40% standardized extracts for more concentrated formulations.

Solubility and formulation: Glabridin is fat-soluble (log P ~3.5). A water-based formulation must use a solubilized or dispersed form. Liposomal licorice extract or a microemulsion delivery system significantly improves bioavailability compared to simple aqueous extracts. Alternatively, use a standardized oil-soluble licorice extract (e.g., Glycyrrhiza Glabra Root Oil) at 0.1-0.5% in an oil phase for an emulsion-based product.

Synergy with Alpha Arbutin: Combining licorice root extract with alpha arbutin targets melanogenesis through three distinct pathways simultaneously: direct tyrosinase inhibition (glabridin), substrate competition (alpha arbutin), and melanosome transfer suppression (niacinamide). This multi-pathway approach is significantly more effective than single-active formulations for stubborn hyperpigmentation.

Synergy with Centella: Centella asiatica’s asiaticoside and madecassoside compounds complement licorice’s anti-inflammatory activity through the NF-κB pathway, providing enhanced protection against PIH triggers.

Stability: Glabridin is light-sensitive. Package in amber glass or opaque secondary packaging. Final formula pH should be maintained between 4.5 and 7.0 to avoid hydrolysis. Accelerated stability testing at 40°C/75% RH for 8 weeks is recommended prior to launch.

Preservation: Licorice extract contains natural saponins and sugars that can support microbial growth. Use a broad-spectrum preservative system (phenoxyethanol + EHGP at 0.8-1.0% or equivalent). Challenge test to USP 51 standard is mandatory.

Process

Regulatory Status

Licorice root extract (Glycyrrhiza Glabra Root Extract) is approved for cosmetic use across all major markets:

• EU: Listed in CosIng database. Safe for use in all cosmetic categories within standard concentrations.
• ASEAN: Listed in the ASEAN Cosmetic Ingredient (ACI) list. No special restrictions at typical use levels (1-10%).
• Japan: Listed in the Japanese Standards of Quasi-Drug Ingredients (JQJ). Commonly used in skin-brightening quasi-drug products.
• South Korea: Listed in the Korea Cosmetic Ingredient Bank (KCIA). Widely used in functional cosmetics for whitening claims.
• China: Licorice extract is permitted in cosmetics. The ingredient Glycyrrhiza Glabra (Licorice) Root Extract appears in the China NMPA approved cosmetic ingredient list.

Note: Glycyrrhizin in high concentrations may cause mineralocorticoid effects if absorbed systemically in very large quantities. This is not a concern for topical cosmetic use at specified concentrations. However, avoid use in products intended for application to large areas of broken skin.

Formulation Checklist

• [ ] Specify licorice extract by glabridin content (not generic extract name)
• [ ] pH stability confirmed at 40°C for 8 weeks
• [ ] Challenge test (USP 51) passed
• [ ] Human repeat insult patch test (HRIPT) for skin sensitization
• [ ] In-use stability study at tropical conditions (35°C/75% RH)
• [ ] Photostability testing if claiming UV protection or anti-pollution
• [ ] Claims substantiation: in vitro tyrosinase inhibition data + in vivo clinical evidence or consumer perception study

Summary

Licorice root extract is a multi-pathway skin-brightening active that differentiates from single-mechanism actives like kojic acid or arbutin through its combination of direct tyrosinase inhibition, anti-inflammatory activity, and MSH signaling modulation. Clinical evidence supports its efficacy in reducing melasma, PIH, and UV-induced hyperpigmentation in diverse skin types — including the darker Fitzpatrick types prevalent in Southeast Asian markets.

Formulation success depends on three factors: sourcing a glabridin-standardized extract, using appropriate delivery technology for the fat-soluble actives, and pairing with complementary actives that address different nodes of the melanogenesis cascade.

References